Journal
POSTGRADUATE MEDICAL JOURNAL
Volume 79, Issue 933, Pages 367-376Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/pmj.79.933.367
Keywords
-
Categories
Ask authors/readers for more resources
The introduction of recombinant human erythropoietin (RHuEPO) has revolutionised the treatment of patients with anaemia of chronic renal disease. Clinical studies have demonstrated that RHuEPO is also useful in various non-uraemic conditions including haematological and oncological disorders, prematurity, HIV infection, and perioperative therapies. Besides highlighting both the historical and functional aspects of RHuEPO, this review discusses the applications of RHuEPO in clinical practice and the potential problems of RHuEPO treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available